Advicenne (ALDVI)

Currency in EUR
0.96
+0.02(+2.13%)
Closed·
ALDVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.940.98
52 wk Range
0.802.35
Key Statistics
Prev. Close
0.94
Open
0.94
Day's Range
0.94-0.98
52 wk Range
0.8-2.35
Volume
22.71K
Average Volume (3m)
41.74K
1-Year Change
-46.257%
Book Value / Share
-1.86
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALDVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.50
Upside
+264.58%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Advicenne News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3.50
(+264.58% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
20-09-2025
EPS / Forecast
-0.40 / --
Revenue / Forecast
3.27M / --
EPS Revisions
Last 90 days

ALDVI Income Statement

Compare ALDVI to Peers and Sector

Metrics to compare
ALDVI
Peers
Sector
Relationship
P/E Ratio
−1.3x−2.5x−0.6x
PEG Ratio
-0.010.00
Price/Book
−0.5x−1.1x2.6x
Price / LTM Sales
1.7x13.4x3.2x
Upside (Analyst Target)
302.3%75.0%49.4%
Fair Value Upside
Unlock11.3%6.0%Unlock

Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. It offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria. The company also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures. Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France.

Employees
13
Market
France

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
185.00K1.31%173.90K
Other Institutional Investors
5.32M37.54%5.00M
Public Companies & Retail Investors
8.66M61.16%8.15M
Total
14.17M100.00%13.32M

FAQ

What Is the Advicenne (ALDVI) Share Price Today?

The Advicenne share price today is 0.96.

What is the current Advicenne (ALDVI) share price and day range?

As of 12-05-2026, the Advicenne share price is 0.96, with a previous close of 0.94. The share price has ranged from 0.94 to 0.98 today, while the 52-week range spans from 0.80 to 2.35.

What Is the Advicenne Market Cap?

As of today, Advicenne market cap is 13.63M.

What Is the Advicenne (ALDVI) Share Price Target?

The average 12-month share price target for Advicenne is 3.50, with a high estimate of 4 and a low estimate of 3. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +264.58% Upside potential.

From a Technical Analysis Perspective, Is ALDVI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

What Stock Exchange Does Advicenne Trade On?

Advicenne is listed and trades on the Paris Stock Exchange.

What Is the Stock Symbol for Advicenne?

The stock symbol for Advicenne is "ALDVI."

How Many Times Has Advicenne Stock Split?

Advicenne has split 0 times.

How Many Employees Does Advicenne Have?

Advicenne has 13 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.